Abstract
Prolidase is a specific imidodipeptidase involved in collagen degradation. The increase in the enzyme activity is believed to be correlated with the increased intensity of collagen degradation. The aim of this study was to evaluate the serum prolidase activity and its relationship between bone turnover markers and bone mineral density (BMD) in postmenopausal osteoporosis. The study included 45 postmenopausal osteoporotic, 55 postmenopausal nonosteoporotic and 38 premenopausal healthy women. BMD was measured at the femoral neck and lumbar spine with DEXA. T score was more than 2.5 SD below the normal at the lumbar spine or femoral neck in postmenopausal osteoporotic patients. Serum levels of prolidase, C-terminal telopeptide of type I collagen (C-telopeptide), total alkaline phosphatase (ALP), osteocalcin (OC), urinary deoxypyridinoline (Dpd) and urinary creatinine were also assayed. C-telopeptide, total ALP, OC, urinary Dpd levels were significantly higher in postmenopausal osteoporotic group compared with premenopausal women. However, there was no statistical difference in serum prolidase activity between the three groups. There were also no significant correlations between serum prolidase and any biomarkers of bone turnover as well as BMD. To conclude, in postmenopausal osteoporotic women with increased bone turnover, serum prolidase concentration was not correlated with the biomarkers of bone formation or bone resorption and with BMD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brincat MP (2000) Hormone replacement therapy and the skin. Maturitas 35:107–117
Consensus Development Statement (1997) Who are candidates for prevention and treatment for osteoporosis? Osteoporos Int 7:1–6
Erbagci AB, Araz M, Erbagci A, Tarakcioglu M, Namiduru ES (2002) Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin Biochem 35:263–268
Felsenberg D, Boonen S (2005) The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther 27:1–11
Gualicka A, Wolczynski S, Anchim T, Surazynski A, Lesniewicz R, Palka J (2001) Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta. Eur J Biochem 268:2172–2178
Kao WH, Kammerer CM, Schneider JL, Bauer RL, Mitchell BD (2003) Type 2 diabetes is associated with increased bone mineral density in Mexican-American women. Arch Med Res 34:399–406
Karna E, Miltyk W, Wolczynski S, Palka JA (2001) The potential mechanism for glutamine-induced collagen biosynthesis in cultured human skin fibroblasts. Comp Biochem Physiol 130:23–32
Kir ZO, Oner P, Iyidogan YO, Turkmen S, Kocak H, Koser M, Kucucuk SO (2003) Serum prolidase I activity and some bone metabolic markers in patients with breast cancer: in relation to menopausal status. Clin Biochem 36:289–294
Muszynska A, Wolczynski S, Palka J (2001) The mechanism for anthracycline-induced inhibition of collagen biosynthesis. Eur J Pharmacol 411:17–25
Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A (1984) Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem 302:211–215
Namiduru ES, Ozdemir Y, Kutlar I, Ersoy U (2001) A study of prolidase in mothers, their newborn babies and in non-pregnant controls. Arch Gynecol Obstet 265:73–75
Oner P, Gurdol F, Oner-Iyidon Y, Kolanci C, Buyukozturk S (1999) Evaluation of the effect of low-dose oral theophylline therapy on some bone turnover markers and serum prolidase I activity in mild asthmatics. Pharmacol Res 40:189–193
Oxlund H, Mosekilde L, Ortoft G (1996) Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone 19:479–484
Sauerbronn AV, Fonseca AM, Bagnoli VR, Saldiva PH, Pinotti JA (2000) The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 68:35–41
Sumino H, Ichikawa S, Abe M, Endo Y, Nakajima Y, Minegishi T, Ishikawa O, Kurabayashi M (2004) Effects of aging and postmenopausal hypoestrogenism on skin elasticity and bone mineral density in Japanese women. Endocr J 51:159–164
Surazynski A, Jarzabek K, Haczynski J, Laudanski P, Palka J, Wolczynski S (2003) Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. Int J Mol Med 12:803–809
Wolczynski S, Surazynski A, Swiatecka J, Palka J (2001) Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells. Gynecol Endocrinol 15:225–233
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Verit, F.F., Geyikli, I., Yazgan, P. et al. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Arch Gynecol Obstet 274, 133–137 (2006). https://doi.org/10.1007/s00404-006-0148-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-006-0148-9